Share
Agree that expenses are high. Not pleasing to see that volume of expenses. Essentially I pick that there is 3 months before another credit raise.
However If the LCD comes through PEB can recognise 3.6M USD in revenue. $5.6M NZD. That doubles the yearly revenue.
in conjunction to that they can negotiate a payment for the invoices product (17000 tests). This has been invoiced but not paid as there is no LCD. This is $20M USD worth of tests produced. I don’t for one minute believe that PEB will bet the full amount but it shows the potential.
This years test plus last FY back log is $25M NZD. That’s almost half the MC of the company.
I know the company were excited about the study that was produced last year, and its good news that they had this included in the dossier. It’s now a matter of playing a waiting game for confirmation of LCD. I believe it’s when not if!
I believe they are on the home straight.
